Filtros de búsqueda

Lista de obras de

Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization

artículo científico publicado en 2021

Association of COVID-19 RT-qPCR test false-negative rate with patient age, sex and time since diagnosis

artículo científico publicado en 2020

Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities

artículo científico publicado en 2021

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary Study ⬇️

report published in 2021

Decreased SARS-CoV-2 viral load following vaccination

artículo científico publicado en 2021

Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

artículo científico publicado en 2021

Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine

SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates

artículo científico publicado en 2021

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study

artículo científico publicado en 2022

The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data

artículo científico

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel

artículo científico publicado en 2022

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda